Published in Helicobacter on August 07, 2015
Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus. Nat Microbiol (2016) 0.91
Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Portugal. Infect Agent Cancer (2017) 0.75
Enhancement of adherence of Helicobacter pylori to host cells by virus: possible mechanism of development of symptoms of gastric disease. Med Mol Morphol (2017) 0.75
Comprehensive molecular characterization of gastric adenocarcinoma. Nature (2014) 11.93
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18
Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol (1992) 3.33
Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology (2009) 2.39
Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev (1994) 2.26
Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn (2008) 1.82
Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc Natl Acad Sci U S A (2009) 1.79
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology (2010) 1.55
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology (2000) 1.48
Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer (1995) 1.36
Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS (2003) 1.33
Helicobacter pylori multiplex serology. Helicobacter (2009) 1.29
Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect (2009) 1.25
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev (2012) 1.13
Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. Cancer Res (2009) 1.10
High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma. Lab Invest (2008) 1.10
Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J Clin Pathol (2004) 1.04
A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Int J Cancer (2013) 0.95
Regulation of Epstein-Barr virus reactivation from latency. Microbiol Immunol (2014) 0.94
Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J Med Microbiol (2006) 0.92
Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine. PLoS One (2013) 0.87
Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population. Int J Cancer (2013) 0.87
Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer (2013) 0.84
Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol (2016) 1.64
Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer. Endoscopy (2015) 1.50
Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy (2013) 1.19
Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery. PLoS One (2014) 1.17
The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am J Gastroenterol (2014) 1.17
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol (2016) 1.06
Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib. J Thorac Oncol (2016) 0.98
High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer. PLoS One (2014) 0.97
Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience. Surg Endosc (2015) 0.97
A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer. PLoS One (2016) 0.95
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer. Sci Rep (2015) 0.93
Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study. Am J Gastroenterol (2016) 0.92
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet (2016) 0.92
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers. Oncotarget (2016) 0.91
Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women. Hum Mol Genet (2016) 0.87
miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis (2015) 0.85
Gastric duplication cysts in adults: a report of three cases. J Gastric Cancer (2015) 0.84
EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs. Clin Cancer Res (2015) 0.83
Clinicopathological factors of multiple lateral margin involvement after endoscopic submucosal dissection for early gastric cancer. Surg Endosc (2015) 0.82
Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplification. Mol Cancer Ther (2014) 0.81
The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients. Oncotarget (2016) 0.81
A Case of Gastric Cancer with Residual Tumor Only in the Para-Aortic Lymph Nodes after Systemic Chemotherapy followed by Conversion Surgery. Case Rep Oncol (2015) 0.81
Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk. Gastroenterology (2016) 0.80
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens. Oncotarget (2015) 0.80
Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer. J Surg Res (2014) 0.80
Pre-operative diagnosis of synchronous solid-pseudopapillary neoplasms of the pancreas. Clin J Gastroenterol (2010) 0.80
Complications leading reoperation after gastrectomy in patients with gastric cancer: frequency, type, and potential causes. J Gastric Cancer (2013) 0.80
A comparative study of telomerase activity and cytologic diagnosis in malignant ascites. Anal Quant Cytopathol Histpathol (2013) 0.80
Aberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profiling. Sci Rep (2014) 0.80
Can endoscopic ultrasound-guided fine needle aspiration offer clinical benefit for tumors of the ampulla of vater? -an initial study. Endosc Ultrasound (2012) 0.80
Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability. Oncotarget (2017) 0.79
Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer. PLoS One (2013) 0.79
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet (2016) 0.79
Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer. Sci Rep (2014) 0.79
The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial. J Gastric Cancer (2016) 0.79
Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population. Cancer Sci (2015) 0.78
Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun. Oncotarget (2015) 0.78
Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer. Int J Cancer (2015) 0.77
Should an Aberrant Left Hepatic Artery Arising from the Left Gastric Artery Be Preserved during Laparoscopic Gastrectomy for Early Gastric Cancer Treatment? J Gastric Cancer (2016) 0.77
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2017) 0.77
Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer. J Cancer Res Clin Oncol (2016) 0.76
Two genetic variants in telomerase-associated protein 1 are associated with stomach cancer risk. J Hum Genet (2016) 0.76
Effect of triclosan-coated sutures on surgical site infection after gastric cancer surgery via midline laparotomy. Ann Surg Treat Res (2014) 0.76
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. Oncotarget (2016) 0.76
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival. Mod Pathol (2016) 0.76
One-dimensional and 2-dimensional tumor size measurement for prediction of lymph node metastasis in differentiated early gastric cancer with minute submucosal invasion. Gastrointest Endosc (2016) 0.76
Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters. Cancer Res Treat (2015) 0.75
Concurrent robot-assisted distal gastrectomy and partial nephrectomy for synchronous early gastric cancer and renal cell carcinoma: an initial experience. J Gastric Cancer (2014) 0.75
Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma. PLoS One (2016) 0.75
Durable response of human epidermal growth factor receptor-2-positive gastric adenosquamous carcinoma to trastuzumab-based chemotherapy. Case Rep Oncol (2014) 0.75
To Excavate Biomarkers Predictive of the Response for Capecitabine plus RAD001 through Nanostring-Based Multigene Assay in Advanced Gastric Cancer Patients. J Cancer (2016) 0.75
Fruit and vegetable intake and the risk of overall cancer in Japanese: A pooled analysis of population-based cohort studies. J Epidemiol (2017) 0.75
Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer. Transl Oncol (2015) 0.75
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Sci Rep (2016) 0.75
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. Br J Cancer (2016) 0.75
Negative Biopsy after Referral for Biopsy-Proven Gastric Cancer. Gut Liver (2016) 0.75
Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry. Breast Cancer Res (2016) 0.75
Molecular Testing for Gastrointestinal Cancer. J Pathol Transl Med (2017) 0.75
Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. Int J Cancer (2017) 0.75
The role of K⁺ conductances in regulating membrane excitability in human gastric corpus smooth muscle. Am J Physiol Gastrointest Liver Physiol (2015) 0.75
Risk Factors and Tumor Recurrence in pT1N0M0 Gastric Cancer after Surgical Treatment. J Gastric Cancer (2016) 0.75
GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development. Cancer Sci (2016) 0.75
Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results. Anticancer Res (2017) 0.75
Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies. J Hepatobiliary Pancreat Sci (2015) 0.75
Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis. J Gastroenterol Hepatol (2017) 0.75
"Pseudoprogression" of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy. J Thorac Oncol (2016) 0.75
Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma. Yonsei Med J (2018) 0.75
Incidence and risk factors for anastomotic stenosis of continuous hepaticojejunostomy after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci (2016) 0.75
Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine (2015) 0.75
Bridging genomics and phenomics of gastric carcinoma. Int J Cancer (2019) 0.75
Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT). Psychooncology (2015) 0.75
Rb loss and KRAS mutation are predictors of the response to platinum-based chemotherapy in pancreatic neuroendocrine neoplasm with grade 3: A Japanese multicenter pancreatic NEN-G3 study. Clin Cancer Res (2017) 0.75
Multiple Primary Malignancies in Patients with Multiple Early Gastric Cancer. J Gastric Cancer (2017) 0.75
Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. Int J Clin Oncol (2016) 0.75
Estimation of the pathological invasive size of pulmonary adenocarcinoma using high-resolution computed tomography of the chest: A consideration based on lung and mediastinal window settings. Lung Cancer (2016) 0.75
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma. Cancer (2017) 0.75
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Res (2017) 0.75
Clinical Efficacy of Alectinib in Patients with ALK-Rearranged Non-small Cell Lung Cancer After Ceritinib Failure. Anticancer Res (2017) 0.75
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. Hum Mol Genet (2016) 0.75
Plexiform Angiomyxoid Myofibroblastic Tumor of the Stomach: a Rare Case. J Gastric Cancer (2017) 0.75
Smoking cessation and subsequent risk of cancer: A pooled analysis of eight population-based cohort studies in Japan. Cancer Epidemiol (2017) 0.75
Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Am J Hematol (2017) 0.75
Coffee consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling Project consortium. Eur J Cancer Prev (2022) 0.75
Alcohol consumption and gastric cancer risk - A pooled analysis within the StoP Project Consortium. Int J Cancer (2017) 0.75
MYB, MYBL1, MYBL2, and NFIB Gene Alterations and MYC Overexpression in Salivary Gland Adenoid Cystic Carcinoma. Histopathology (2017) 0.75
Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. Int J Hematol (2016) 0.75